Your session is about to expire
← Back to Search
Plasma Device
Plasma Treatment for Acne/Rosacea
N/A
Recruiting
Research Sponsored by The Skin Center Dermatology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnoses of target conditions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial found that a device that emits plasma can help improve skin conditions.
Who is the study for?
This trial is for individuals with certain skin conditions like Molluscum Contagiosum, Bowen's Disease, warts, and various forms of keratosis and acne. Participants must be able to follow the study procedures. Specific exclusions depend on the individual's condition.
What is being tested?
The study is testing a device that uses cold atmospheric plasma to treat different skin disorders including lesions and acne. It also looks at using this technology indirectly to help with hair loss associated with these skin conditions.
What are the potential side effects?
Potential side effects may include temporary redness, irritation or discomfort at the treatment site. Since it's non-thermal plasma, heat-related injuries are unlikely.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with the specific condition required.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1-12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Clinical improvement
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Non-thermal atmospheric plasma treatmentExperimental Treatment1 Intervention
Device treatment
Group II: Indirect non-thermal atmospheric plasma treatmentExperimental Treatment1 Intervention
A compound of non-thermal atmospheric plasma and medium is used to treat the target by direct application or by on-site generation of the compound
Find a Location
Who is running the clinical trial?
The Skin Center Dermatology GroupLead Sponsor
3 Previous Clinical Trials
62 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- This criterion is not specific enough to provide a simplified summary. Can you please provide more details or context?I have been diagnosed with the specific condition required.I have been diagnosed with the specific condition required.
Research Study Groups:
This trial has the following groups:- Group 1: Non-thermal atmospheric plasma treatment
- Group 2: Indirect non-thermal atmospheric plasma treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.